Synthesis and Biological Evaluation of Novel 2-Aminonicotinamide Derivatives as Antifungal Agents. 2017

Tingjunhong Ni, and Ran Li, and Fei Xie, and Jing Zhao, and Xin Huang, and Maomao An, and Chengxu Zang, and Zhan Cai, and Dazhi Zhang, and Yuanying Jiang
School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai, 200433, China.

Based on the structures of the reported compounds G884 [N-(3-(pentan-2-yloxy)phenyl)nicotinamide], E1210 [3-(3-(4-((pyridin-2-yloxy)methyl)benzyl)isoxazol-5-yl)pyridin-2-amine], and 10 b [2-amino-N-((5-(3-fluorophenoxy)thiophen-2-yl)methyl)nicotinamide], which inhibit the biosynthesis of glycosylphosphatidylinositol (GPI)-anchored proteins in fungi, a series of novel 2-aminonicotinamide derivatives were designed, synthesized, and evaluated for in vitro antifungal activity. Most of these compounds were found to exhibit potent in vitro antifungal activity against Candida albicans, with MIC80 values ranging from 0.0313 to 4.0 μg mL-1 . In particular, compounds 11 g [2-amino-N-((5-(((2-fluorophenyl)amino)methyl)thiophen-2-yl)methyl)nicotinamide] and 11 h [2-amino-N-((5-(((3-fluorophenyl)amino)methyl)thiophen-2-yl)methyl)nicotinamide] displayed excellent activity against C. albicans, with MIC80 values of 0.0313 μg mL-1 , and exhibited broad-spectrum antifungal activity against fluconazole-resistant C. albicans, C. parapsilosis, C. glabrata, and Cryptococcus neoformans, with a MIC80 range of 0.0313-2.0 μg mL-1 . Further studies by electron microscopy and laser confocal microscopy indicated that compound 11 g targets the cell wall and decreases GPI anchor content on the cell surface of C. albicans.

UI MeSH Term Description Entries
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D009536 Niacinamide An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and PELLAGRA. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake. Nicotinamide,Vitamin B 3,Vitamin PP,3-Pyridinecarboxamide,Enduramide,Nicobion,Nicotinsäureamid Jenapharm,Papulex,Vitamin B3,3 Pyridinecarboxamide,B 3, Vitamin,B3, Vitamin,Jenapharm, Nicotinsäureamid
D002175 Candida A genus of yeast-like mitosporic Saccharomycetales fungi characterized by producing yeast cells, mycelia, pseudomycelia, and blastophores. It is commonly part of the normal flora of the skin, mouth, intestinal tract, and vagina, but can cause a variety of infections, including CANDIDIASIS; ONYCHOMYCOSIS; VULVOVAGINAL CANDIDIASIS; and CANDIDIASIS, ORAL (THRUSH). Candida guilliermondii var. nitratophila,Candida utilis,Cyberlindnera jadinii,Hansenula jadinii,Lindnera jadinii,Monilia,Pichia jadinii,Saccharomyces jadinii,Torula utilis,Torulopsis utilis,Monilias
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D003455 Cryptococcus neoformans A species of the fungus CRYPTOCOCCUS. Its teleomorph is Filobasidiella neoformans. Blastomyces neoformans,Debaryomyces neoformans,Filobasidiella neoformans,Lipomyces neoformans,Saccharomyces neoformans,Torula neoformans,Torulopsis neoformans,Cryptococcus neoformans var. grubii
D000631 Aminopyridines Pyridines substituted in any position with an amino group. May be hydrogenated but must retain at least one double bond. Aminopyridine
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Tingjunhong Ni, and Ran Li, and Fei Xie, and Jing Zhao, and Xin Huang, and Maomao An, and Chengxu Zang, and Zhan Cai, and Dazhi Zhang, and Yuanying Jiang
August 2014, Bioorganic & medicinal chemistry letters,
Tingjunhong Ni, and Ran Li, and Fei Xie, and Jing Zhao, and Xin Huang, and Maomao An, and Chengxu Zang, and Zhan Cai, and Dazhi Zhang, and Yuanying Jiang
December 2010, Chemical biology & drug design,
Tingjunhong Ni, and Ran Li, and Fei Xie, and Jing Zhao, and Xin Huang, and Maomao An, and Chengxu Zang, and Zhan Cai, and Dazhi Zhang, and Yuanying Jiang
May 2015, Molecules (Basel, Switzerland),
Tingjunhong Ni, and Ran Li, and Fei Xie, and Jing Zhao, and Xin Huang, and Maomao An, and Chengxu Zang, and Zhan Cai, and Dazhi Zhang, and Yuanying Jiang
February 2024, RSC medicinal chemistry,
Tingjunhong Ni, and Ran Li, and Fei Xie, and Jing Zhao, and Xin Huang, and Maomao An, and Chengxu Zang, and Zhan Cai, and Dazhi Zhang, and Yuanying Jiang
March 2024, ACS omega,
Tingjunhong Ni, and Ran Li, and Fei Xie, and Jing Zhao, and Xin Huang, and Maomao An, and Chengxu Zang, and Zhan Cai, and Dazhi Zhang, and Yuanying Jiang
February 2016, Journal of pesticide science,
Tingjunhong Ni, and Ran Li, and Fei Xie, and Jing Zhao, and Xin Huang, and Maomao An, and Chengxu Zang, and Zhan Cai, and Dazhi Zhang, and Yuanying Jiang
October 2002, Bioorganic & medicinal chemistry letters,
Tingjunhong Ni, and Ran Li, and Fei Xie, and Jing Zhao, and Xin Huang, and Maomao An, and Chengxu Zang, and Zhan Cai, and Dazhi Zhang, and Yuanying Jiang
September 2015, Bioorganic & medicinal chemistry letters,
Tingjunhong Ni, and Ran Li, and Fei Xie, and Jing Zhao, and Xin Huang, and Maomao An, and Chengxu Zang, and Zhan Cai, and Dazhi Zhang, and Yuanying Jiang
April 2024, ACS omega,
Tingjunhong Ni, and Ran Li, and Fei Xie, and Jing Zhao, and Xin Huang, and Maomao An, and Chengxu Zang, and Zhan Cai, and Dazhi Zhang, and Yuanying Jiang
January 2016, European journal of medicinal chemistry,
Copied contents to your clipboard!